Avelumab Appears to be Effective in Preventing Relapse in Women With GTT

The phase II study was the first trial to explore the use of immunotherapy for patients who were resistant to standard chemotherapy treatment

Source: CancerNetwork - May 28, 2020 Category: Cancer & Oncology Authors: Kevin Wright Source Type: news